Lilly's Olympics Ad Promises To 'Fight Like Hell' For Athletes
Eli Lilly's Olympic campaign urges fighting for health, featuring diverse athletes and strong messaging.
Breaking News
Jul 30, 2024
Mrudula Kulkarni

Eli Lilly has launched a new campaign to coincide with the
Olympic Games, delivering a powerful message: “You only get one body, let's
fight like hell for it.” In partnership with Team USA, the pharmaceutical giant
highlights that while anybody can fall ill, no one should simply accept it. The
60-second ad showcases the diverse forms of Olympian bodies, featuring a
basketball player, a gymnast's aerial view, a weightlifter, and a Paralympian
runner. The narration emphasizes the uniqueness of each athlete, stating that
your body might “stand seven feet tall,” be ideal for gymnastics, “take up a
lot of space,” or “move differently.”
Athletes and everyone else share a common destiny: their
bodies might eventually get sick. “No matter how strong you are, your health
may still slip out of your control,” the voice-over states. However, the ad
makes a clear distinction between inevitability and acceptance regarding this
reality. “You don't have to accept that,” the voice-over continues. “Consider
this: around a billion things had to align perfectly for you to be born. And
since you only get one body, let's fight like hell for it.” These powerful
words accompany scenes of a newborn baby entering the world, meeting a
healthcare professional, and then their mother for the first time.
Lilly has teamed up with over 25 Olympians to promote their
film on social media during the games. Suni Lee, the Team USA gymnast featured
in the ad, has already shared it on Instagram. Through its agreements with the
U.S. Olympic and Paralympic teams and NBCUniversal, the U.S. media partner for
the games, Lilly has managed to gain visibility despite Sanofi sponsoring the
games in Paris. Both pharmaceutical companies are running extensive campaigns
during the Olympics. Lilly has made U.S. gymnast Simone Biles the spokesperson
for its GLP-1 drug Mounjaro, while Sanofi is pushing a variety of digital and
real-world materials as part of its largest corporate initiative to date.